BLOOD ACADEMY
Webinar Series 2022
Join our panel of haematology experts in conversation for a series of live webinars.
These 1-hour continuing professional development (CPD) sessions are an opportunity to gain new knowledge, explore niche topics, debate current issues, address less talked about themes and open the conversation. Topics will cover a diverse range of disciplines across haematology.
Get your Certificate
Blood Academy subscribers will receive a Certificate for every webinar attended and will have permanent access.
Free users will be able to watch live on the day on YouTube.
Not a subscriber yet?
Watch in YouTube
Clonal hematopoiesis in clinical practice.
The good the bad and the ugly
21/3/22 - 3PM GMT
Dr Danielle Hammond,
MD Anderson Cancer Centre Texas, USA
Access webinar recording and certificate
Dr. Hammond received her M.D. degree from The University of Ottawa, Ottawa, Canada. She is a graduate of the University of Toronto Internal Medicine Core Residency and completed her Adult Hematology Residency at Queen’s University in Kingston, Canada. She is board-certified with The Royal College of Physicians and Surgeons of Canada in both Adult Hematology and Internal Medicine. She subsequently completed a 2-year fellowship at the University of Texas MD Anderson Cancer Center, serving as the Chief Leukemia Fellow FY 2020-2021.
Dr. Hammond is currently an Assistant Professor in the Department of Leukemia, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas. Her clinical and academic focuses include select myeloid neoplasms (AML, MDS, CMML), acquired and constitutional bone marrow failure states, and familial predisposition to leukemias/marrow failure. Dr. Hammond is also involved in the development of a clinical clonal hematopoiesis program, aimed at investigating and mitigating the adverse consequences of this pre-malignant state, including preventing leukemic transformation and the inflammation-mediated diseases of aging, as outlined in her 2021 review article in the journal Pathology. Dr. Hammond’s other recent original research and review works have been published in: American Journal of Hematology, Current Hematologic Malignancy Reports, Hematology/Oncology Clinics of North America, Leukemia, and Transfusion. She is also the recent recipient of American Society of Hematology (ASH) Abstract Achievement and American Society of Clinical Oncology Conquer Cancer Abstract Merit Awards.
Dr. Hammond also enjoys medical education writing, serving 3 years as an editor and contributor to The Microenvironment, a Canadian Hematology Society publication, and writing for the 2020 ASH News Daily. She currently acts as a malignant hematology content expert and continuing medical education contributor to “Figure 1”, a social networking-based education application for healthcare professionals. Her favorite quote is “hematology is the study of blood and the tissues through which it flows.”
Morphologic Clues to Underlying Genetic Alterations in Myeloid Malignancies
18/4/22 - 3PM GMT
Dr Kamran Mirza,
Loyola University Chicago, USA
Access webinar recording and certificate
Kamran Muhammad Mirza has completed his MBBS from the Aga Khan University in Karachi, Pakistan and PhD from University of Illinois in Chicago, IL. He was trained in Combined Anatomic and Clinical Pathology with Fellowships in Hematopathology, Thoracic Pathology and Medical Education at the University of Chicago. He is an Assistant Professor of Pathology and Medical Director of Molecular Pathology at Loyola University Chicago Stritch School of Medicine in Maywood, IL. He is the recipient of numerous pathologist-in-training awards, teacher-of-the year awards and honors such as induction into the Alpha Omega Alpha honor society and selection into American Society for Clinical Pathology’s 40 Under Forty 2017.
Update in cancer-associated thrombosis
16/5/22 - 3PM GMT
Prof. Simon Noble,
Cardiff University, UK
Access webinar recording and certificate
Professor Simon Noble hold a Marie Curie Chair in Supportive and Palliative Medicine and acts as co-director of the Marie Curie Palliative Care Research Group, which sits in the Division of Population Medicine. He is also an honorary consultant in Palliative Medicine at Aneurin Bevan University Health Board
His research and clinical interests lie with cancer-associated thrombosis with particular emphasis on the management in advanced cancer and where the evidence is lacking. Simon has collaborated with international researchers to explore the impact of cancer-associated thrombosis on the lives of patients with cancer-associated thrombosis and is a strong advocate for patient partners working in all aspects of thrombosis research.
He has lectured in over 40 countries across five continents and his hobbies include trekking, the history of cinema and hip-hop.
Venous thromboembolism risk assessment during pregnancy- a case based review
13/6/22 - 3PM GMT
Dr Sajida Kazi,
Newcastle Upon Tyne NHS Hospitals Foundation Trust, UK
Access webinar recording and certificate
Dr Sajida Kazi is a Staff Physician in benign haematology at Newcastle Upon Tyne NHS Hospitals Foundation Trust, UK. Her interests include Thrombosis and Obstetric Haematology. She has completed her Medical and Haematology training in the United Kingdom and a clinical fellowship program in Obstetric Haematology from the University of Toronto. She is pursuing a master’s in medical education from the University of Edinburgh, UK and is actively involved in both undergraduate and Postgraduate teaching programs at Newcastle University. She is a member of the British Society for Haematology Obstetric Haematology special interest group and is involved with research projects in benign Haematology. She is also involved with ISTH Women’s health in Haemostasis and Thrombosis Registry on COVID-19 coagulopathy in Pregnancy (COV-PREG-COAG).
EBV-related lymphoproliferative disorders
18/7/22 - 3PM GMT
Genevieve (Eve) Crane, MD, PhD is a Staff Hematopathologist and Associate Director of the Immunohistochemistry Laboratory at the Cleveland Clinic Robert J. Tomsich Pathology and Laboratory Medicine Institute. She received a B.S. summa cum laude in Chemical Engineering from Rice University, a M.Phil. from University College London as a British Marshall Scholar and M.D. and Ph.D. degrees from the University of Michigan as part of the Medical Scientist Training Program. She did postdoctoral work at MIT before completing a residency in Anatomic Pathology and a fellowship in Hematopathology at Johns Hopkins Hospital. Dr. Crane has authored more than 50 journal articles, has 2 related patents and co-authored the recent textbook, Survival Guide to Lymph Node Pathology. She is a Section Editor for Hematopathology at Archives of Pathology and Laboratory Medicine and a Deputy-Editor-in-Chief at PathologyOutlines.com. She is actively involved in multiple pathology societies including serving as the current chair of the Communications Committee for the Society of Hematopathology. She is passionate about developing novel methods for pathology education and outreach, including through social media.
Nightmare on blood smear street - Emergency presentations
17/10/22 - 3PM GMT
Dr Ali Mahdi is a consultant haematologist at Aneurin Bevan University Health Board where he has a specialist interest in myeloid malignancies and haematology diagnostics. He is the co-founder of Blood Academy and over the past 6 years been active in various educational projects on the platform. He is a member of the NCRI group for chronic myeloid leukaemia and has a keen interest in research acting as principal investigator on a number of clinical studies.
Update in the management of diffuse large B-cell lymphoma
21/11/22 - 3PM GMT
Dr Matthew Wilson,
Queen Elizabeth University Hospital, Glasgow, UK
Access webinar recording and certificate
Dr Matthew Wilson is a Consultant Haematologist and Honorary Senior Clinical Lecturer at the Queen Elizabeth University Hospital in Glasgow, where he specialises in Lymphoma, Bone Marrow Transplant and Cellular Therapy. He completed haematology training in Glasgow, including a fellowship in lymphoma at the Beatson West of Scotland Cancer Centre, as well as completing a diploma in lymphoid malignancies with the European School of Oncology. He has co-authored several papers and guidelines on lymphoma and presented at international meetings. He has a particular interest in the prevention and management of central nervous system relapse in diffuse large B-cell lymphoma.